Showing 211-220 of 345 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Sensor for early detection of immune activation in diabetes | Regents of the University of Michigan | Lonnie Shea | Cures | 01-January-2024 to 28-February-2026 | $300.000,00 |
| Cell capture scaffold to monitor islet transplant rejection | Regents of the University of Michigan | Lonnie Shea | Cures | 01-September-2023 to 28-February-2026 | $600.000,00 |
| Cooperative harmonization and validation of an islet-specific AIM assay | Benaroya Research Institute at Virginia Mason | Karen Cerosaletti | Cures | 01-February-2024 to 31-January-2027 | $299.998,00 |
| Evaluation of Oxidized Insulin as a Biomarker and Therapeutic Target in Type 1 Diabetes | Trustees of Indiana University | Amelia Linnemann | Cures | 01-October-2023 to 30-September-2026 | $560.000,00 |
| Immune-checkpoint engineered beta cells as treatment for T1D | UT Southwestern | Andrew Wang | Cures | 01-October-2023 to 30-September-2026 | $746.818,40 |
| Development of Allosteric G6PC1 Partial Inhibitors | Vanderbilt University | Richard O’Brien | Improving Lives | 01-October-2023 to 08-August-2026 | $549.940,00 |
| A New Preparation of the Intact Eye for Measurements of Retinal Dysfunction in Acute Hyperglycemia and Early Diabetes | Northwestern University | Gregory Schwartz | Improving Lives | 01-October-2023 to 30-September-2026 | $406.927,40 |
| Enhance β-Cell Replacement Therapies via Localized Immune Modulation Using DIANA Nanocarriers | University of Miami | Peter Buchwald | Cures | 01-September-2023 to 31-August-2026 | $900.000,00 |
| A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation | The University of Chicago | Piotr Witkowski | Cures | 01-February-2024 to 31-October-2026 | $250.000,00 |
| Armored SC-beta | The Regents of the University of California, San Francisco | Qizhi Tang | Cures | 01-December-2023 to 28-February-2026 | $499.999,25 |